Vector Database
Trademarks:
- Zeocin® is an InvivoGen trademark.
173 Results for: pcDNA
0—25 of 173
Name | Vector Type | Resistance Marker | Bacterial Resistance | Source | Sequence Available |
---|---|---|---|---|---|
1436 pcDNA3 Flag HA | Mammalian Expression | Neomycin | Ampicillin | Addgene | |
7. pCD33_Exon1-7_plus introns_C_Extended pY | Petra van Bergeijk and Samuel A. Hasson | ||||
7. pCD33_Exon1-7_plus introns_T_Extended pY | Petra van Bergeijk and Samuel A. Hasson | ||||
c-Flag pcDNA3 | Mammalian Expression | Neomycin | Ampicillin | Addgene | |
FLAG-HA-pcDNA3.1- | Mammalian Expression | Neomycin (select with G418) | Addgene | ||
FNpCDNA3 | Mammalian Expression | Neomycin | Ampicillin | Addgene | |
HA-BirA*-pDEST-N-pcDNA5/FRT/TO | Mammalian Expression | Addgene | |||
miR-722-Dendra pCDNA | Mammalian Expression | Addgene | |||
miR-vector-RFP pCDNA | Mammalian Expression | Addgene | |||
pBabe HcRed | Mammalian Expression, Retroviral | Ampicillin | Addgene | ||
PCD FL0X | Mammalian Expression, Luciferase | Neomycin | Ampicillin | Addgene | |
pCD33_Exon 1-4_plus introns_C | Petra van Bergeijk and Samuel A. Hasson | ||||
pCD33_Exon 1-4_plus introns_T | Petra van Bergeijk and Samuel A. Hasson | ||||
pCD33_Exon 1-7_minus introns_C | Petra van Bergeijk and Samuel A. Hasson | ||||
pCD33_Exon 1-7_minus introns_T | Petra van Bergeijk and Samuel A. Hasson | ||||
pCD33_Exon 1-7_plus introns_C | Petra van Bergeijk and Samuel A. Hasson | ||||
pCD33_Exon 1-7_plus introns_T | Petra van Bergeijk and Samuel A. Hasson | ||||
pcDNA DEST40 | Mammalian Expression | Ampicillin | Invitrogen | ||
pcDNA-DEST47 | Mammalian Expression | Neomycin | Ampicillin | Invitrogen | |
pcDNA-DEST53 | Mammalian Expression | Neomycin | Ampicillin | Invitrogen | |
pcDNA1 | Mammalian Expression | Other | Invitrogen | ||
pcDNA1.1 | Unspecified | Other | Invitrogen | ||
pcDNA1.1/Amp | Unspecified | Ampicillin | Invitrogen | ||
pcDNA3 | Mammalian Expression | Neomycin | Ampicillin | Invitrogen | |
pcDNA3 DSred express2 | Mammalian Expression | Addgene |